🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
The aim of the study is to assess the effect of dexamethasone on labour ind...
Status
Recruiting
Location
Cairo University Hospital (Kasr Al Ainy)
Start Date
2025-05-01
Trial ID
NCT07109258
This study evaluated whether giving a single dose of long-acting corticoste...
Status
Active Not Recruiting
Location
Department of Oral & Maxillofacial Surgery, Al Salam University
Start Date
2026-01-04
Trial ID
NCT07450638
Treatments Being Tested
This study evaluates the value of bortezomib in combination with specified ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2013-03
Trial ID
NCT01769209
Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive form of ...
Status
Unknown
Location
Department of Medical Oncology, Sun Yat-sen University Cancer Center,
Start Date
2013-04-25
Trial ID
NCT02085655
Treatments Being Tested
This is a phase I/II study of an investigational drug called ABT-751, produ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2006-05-22
Trial ID
NCT00439296
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2000-04
Trial ID
NCT00005596
This prospective, randomized, multicenter, open-label Phase 2 study is desi...
Status
Recruiting
Location
St. Anna Kinderspital
Start Date
2023-05-17
Trial ID
NCT05748171
Treatments Being Tested
Olanzapine-containing regimens for CINV prophylaxis may provide even better...
Status
Unknown
Location
N.N. Blokhin Cancer Research Center
Start Date
2018-05-25
Trial ID
NCT03478605
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
MBCCOP - University of South Alabama
Start Date
1995-07
Trial ID
NCT00002665